Year-End Report
TIBER CREEK GROUP for AMGEN INC
Firm
Client
Income
$100,000
Expenses
—
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
Intellectual property and process patent issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID E JOHNSON | N/A |
| JONATHON JONES | COS, SEN. CARPER |
Health Issues HCR
Food and Drug Administration Amendments Act of 2007 (PL.110-85). HR.1956, Patient Protection and Innovative Biologic Medicines Act of 2007.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID E JOHNSON | N/A |
| JONATHON JONES | COS, SEN. CARPER |
Medicare/Medicaid MMM
Coverage and reimbursement of erythropoiesis-stimulating agent (ESA products) = SJ RES.22.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID E JOHNSON | N/A |
| JONATHON JONES | COS, SEN. CARPER |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.